Ehud Lavi, M.D.

Anatomic Pathology and Clinical Pathology
Ehud Lavi

Ehud Lavi, M.D. is a Professor of Pathology and Laboratory Medicine, and Chief of the Neuropathology Service at Weill Cornell Medical College. He is providing service and consultations on all aspects of pathology of the brain, spinal cord, peripheral nerve and muscle.

Dr. Lavi has research interests in neurovirology and neuroimmunology. He investigates viral diseases of the central nervous system (CNS), including coronaviruses, HIV, and herpes viruses among others.  He has been exploring viral and autoimmune experimental models of multiple sclerosis and CNS vasculitis. The focus of the investigation included the study of the interaction between viruses and the CNS, the role of astrocytes and microglia in cytokine and chemokine immune modulating signaling, the role of chemokine receptors in HIV infection of the brain, and the role of viral glycoproteins in neurotropism.

Ehud Lavi, M.D. received his medical degree from the Technion, Israel Institute of Technology, and did a Neurology residency at Hadassah Hospital- The Hebrew University School of Medicine in Jerusalem, Israel. Following a research fellowship in Neurovirology at the University of Pennsylvania and the Wistar Institute in Philadelphia, he trained in Anatomic Pathology at Pennsylvania Hospital in Philadelphia, followed by a Neuropathology fellowship at the Hospital of the University of Pennsylvania. In 1991 he joined the faculty of the University of Pennsylvania, where he served as Attending Neuropathologist until 2005 when he came to Cornell University.

Dr. Lavi published over 150 scientific publications, including research articles in the fields of neurovirology, neuroimmunology and neuropathology, reviews, editorials, and book chapters. Dr. Lavi published a book on Nidoviruses ( 2000) and a book on Experimental Models of Multiple Sclerosis (2005). Dr. Lavi served on study sections for the NIH, and the Department of Agriculture. He chaired the organizing committee of the 2000 International symposium on Nidoviruses. Dr. Lavi served on the editorial board of the Journal of Neuropathology and Experimental Neurology (1995-1998) and on the Board of Directors of the International Society for Neurovirology. He is a member of the Editorial Board of the Journal of Neurovirology.

Insurances

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please feel free to contact this physician or this physician's practice as they may have individual contracts not included on this site.

  • AETNA [HMO]
  • AETNA [PPO]
  • AETNA [Medicare]
  • Aetna - Weill Cornell [POS]
  • Affinity Essential
  • Affinity Health Plan
  • Blue Priority Network
  • CIGNA
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield [Pathway X]
  • Empire Blue Cross/Blue Shield [Pathway X Enhanced]
  • Empire Blue Cross/Blue Shield [PPO]
  • Empire Blue Cross/Blue Shield [EPO]
  • Empire Blue Cross/Blue Shield [HMO]
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Fidelis Care
  • GHI [CBP]
  • Health First
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP)
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Plus - Amerigroup [CHP]
  • Health Plus - Amerigroup
  • Health Republic
  • Medicare [Medicare]
  • Oscar
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Freedom]
  • POMCO
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care
  • United Health Care [Medicare]
  • United Health Care [Community Plan]
  • VNSNY CHOICE Medicare [Medicare]
  • VNSNY CHOICE Medicare [HMO]

Publications

Gonzales DM, Fu L, Li Y, Das Sarma J, Lavi E. Coronavirus-induced demyelination occurs in the absence of CD28 co-stimulatory signals. J. Neuroimmunol. 146:140-143,2004.

Fu L, Gonzales DM, Das Sarma J, Lavi E. A combination of mutations in the S1 part of the spike glycoprotein gene of coronavirus MHV-A59 abolishes demyelination. J. Neurovirol. 10:41-51, 2004

Li Y, Fu L, Gonzales DM, Lavi E. Coronavirus neurovirulence correlates with the ability of the virus to induce pro-inflammatory cytokine signals by astrocytes and microglia. J. Virol. 78: 3398-3406, 2004.

Coley SE, Lavi E, Sawicki SG, Fu L, Schelle B, Karl N, Siddell SG, Thiel V. Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo. J. Virol. 79:3097-3106,2005.

Honors and Awards

1982    Penn-Israel Wexler Fellowship Award.

1991 NIH sponsored, Biomedical Research Support Grant (BRSG),

   University of Pennsylvania.

1991    The Thomas B. McCabe and Jeannette E. Laws McCabe Award

1993    University of Pennsylvania Research Foundation Award

1996 The “Representative James Greenwood grant on “Molecular control of coronavirus induced demyelination”. The 1996 National Multiple Sclerosis Society Representative of the Year.

2001    Member, The John Morgan Society, University of Pennsylvania.